目的探讨CT对恶性胸膜间皮瘤的诊断与鉴别诊断价值。
Objective To explore the usefulness of ct in the diagnosis and differential diagnosis of malignant pleural mesothelioma.
培美曲塞二钠是唯一治疗恶性胸膜间皮瘤（MPM）的药物。
Pemetrexed disodium is the only agent for the treatment of malignant pleural mesothelioma(MPM).
正应为如此，当大多数人们说道间皮瘤时，他们常是在说恶性胸膜间皮瘤。
Because of this, when most people speak of "mesothelioma", they are usually speaking of malignant pleural mesothelioma.
培美曲塞是一种多靶点的抗代谢类药物，目前已经在70余个国家批准上市，用于治疗恶性胸膜间皮瘤和非小细胞肺癌。
Pemetrexed is a multitargeted antimetabolite that has shown activity in malignant pleural mesothelioma and NSCLC, which has been approved in more than 70 countries.
当胸膜的恶性病变侵及肺，肿瘤的原发灶仍是胸膜，因此胸膜间皮瘤是不能被当成肺癌治疗。
While a pleural malignancy can invade the lung, the tumor's origin site is still the pleura, so pleural mesothelioma should never be treated as lung cancer.
当胸膜的恶性病变侵及肺，肿瘤的原发灶仍是胸膜，因此胸膜间皮瘤是不能被当成肺癌治疗。
While a pleural malignancy can invade the lung, the tumor's origin site is still the pleura, so pleural mesothelioma should never be treated as lung cancer.
应用推荐